BeStock  
Stocks › Biotechnology › RARE

Ultragenyx Pharmaceutical RARE

US equityMarket cap rank #2801Biotechnology
$16.48 −$0.74 (-4.30%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $16.50 +0.12%
Open$16.94
Prev close$17.22
Day range$16.43 – $17.35
Volume3.01M
Market cap$1.68B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts19
Average target$25.39+54.1% vs. price
  • Buy 47%
  • Hold 53%
Low $16.00Now $16.48Avg $25.39High $39.00

Recent rating changes

The last 20 actions on file set price targets from $16.00 to $39.00, averaging $25.15.

DateFirmRatingTarget
6 Nov 2026 Citi BUY $22.00
6 Nov 2026 H.C. Wainwright BUY $25.00
5 Nov 2026 Piper Sandler BUY $36.00
5 Nov 2026 Citi BUY $22.00
5 Nov 2026 Leerink Partners BUY $33.00
5 Nov 2026 H.C. Wainwright BUY $25.00
5 Nov 2026 Barclays BUY $32.00
4 Nov 2026 TD Cowen BUY $19.00
4 Nov 2026 CCORF BUY $34.00
4 Nov 2026 BofA Securities HOLD $20.00
4 Nov 2026 Wedbush HOLD $22.00
4 Nov 2026 Morgan Stanley HOLD $22.00
4 Nov 2026 Goldman Sachs HOLD $17.00
4 Nov 2026 RBC Capital HOLD $19.00
3 Nov 2026 Cantor Fitzgerald BUY $39.00
3 Nov 2026 Wells Fargo HOLD $19.00
3 Nov 2026 BofA Securities HOLD $20.00
21 Oct 2026 Piper Sandler BUY $36.00
15 Oct 2026 UBS HOLD $16.00
15 Oct 2026 H.C. Wainwright BUY $25.00

Discussion

No comments yet — be the first to weigh in on RARE.

Sign in to join the discussion.

Scroll to Top